CORRECTION: An earlier version of this story said Health Canada had approved several generics for semaglutide. They have received several submissions for approval for ...

A group of 42 US states and territories has filed a fresh antitrust lawsuit accusing Swiss pharma Novartis (NOVN: VX) and its former generics unit Sandoz (SIX: SDZ) of colluding to fix prices and ...

Sun Pharmaceutical Industries is looking to stabilise its US generics business as manufacturing compliance improves and new product launches resume, while sharpening its strategic focus on ...

https://www.thehindubusinessline.com/companies/lupin-launches-generic-cancer-drug-in-us/article70582493.ece Copy Drug firm Lupin on Monday said it has launched a ...

Highmark recently shared how it increased generic and biosimilar access to members, focusing on drugs for multiple sclerosis, cancer and autoimmune conditions. The insurer has been working with ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. A similar scenario is now ...

The fun part about a programming language like C is that although the language doesn’t directly support many features including object-oriented programming and generics, there’s nothing that’s keeping ...

Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...

CEO Narasimhan says no tariff impact on guidance Top-selling heart drug Entresto sees growth stall Older drugs hit by 'generic erosion' in US market Newer drugs help offset some of the slowdown ...